You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.
To the Editor.The article by Dr Gottschalk and colleagues1is misleading and not clinically relevant and represents neitheroptimal care nor standard of care in prostate cancer patientsundergoing radical prostatectomy. Their hypothesis concerningthe value of preemptive analgesia and the study design to testthis question may be appropriate in many clinical settings butnot for radical prostatectomy. The use of epidural analgesiais neither cost-effective nor necessary to provide excellentpostoperative pain control after this procedure.
Quality of care and cost-effectiveness of radical prostatectomyhave received substantial attention in the urologic literature.Many centers have developed and described clinical care pathwaysoutlining such care.2-4 Our experience with a clinical carepathway similar to those reported demonstrates that intravenousketorolac administered at the time of fascial closure and continuedevery 6 hours provides excellent pain control. Patients areroutinely out of bed the day of surgery, start drinking . . . [Full Text of this Article]